اوله‌سوکسیم (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "اوله‌سوکسیم" in Persian language version.

refsWebsite
Global rank Persian rank
1st place
1st place
4th place
5th place
low place
low place
low place
low place
2nd place
2nd place

doi.org

  • Bertini, Enrico; Dessaud, Eric; Mercuri, Eugenio; Muntoni, Francesco; Kirschner, Janbernd; Reid, Carol; Lusakowska, Anna; Comi, Giacomo P; Cuisset, Jean-Marie; Abitbol, Jean-Louis; Scherrer, Bruno; Ducray, Patricia Sanwald; Buchbjerg, Jeppe; Vianna, Eduardo; Van Der Pol, W Ludo; Vuillerot, Carole; Blaettler, Thomas; Fontoura, Paulo; André, Carole; Bruno, Claudio; Chabrol, Brigitte; Deconinck, Nicolas; Estournet, Brigitte; Fontaine-Carbonnel, Stephanie; Goemans, Nathalie; Gorni, Ksenija; Govoni, Alessandra; Guglieri, Michela; Lochmuller, Hanns; et al. (2017). "Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: A randomised, double-blind, placebo-controlled phase 2 trial". The Lancet Neurology. 16 (7): 513. doi:10.1016/S1474-4422(17)30085-6. PMID 28460889.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Martin LJ (August 2010). "Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis". IDrugs. 13 (8): 568–80. PMC 3058503. PMID 20721828.
  • Bertini, Enrico; Dessaud, Eric; Mercuri, Eugenio; Muntoni, Francesco; Kirschner, Janbernd; Reid, Carol; Lusakowska, Anna; Comi, Giacomo P; Cuisset, Jean-Marie; Abitbol, Jean-Louis; Scherrer, Bruno; Ducray, Patricia Sanwald; Buchbjerg, Jeppe; Vianna, Eduardo; Van Der Pol, W Ludo; Vuillerot, Carole; Blaettler, Thomas; Fontoura, Paulo; André, Carole; Bruno, Claudio; Chabrol, Brigitte; Deconinck, Nicolas; Estournet, Brigitte; Fontaine-Carbonnel, Stephanie; Goemans, Nathalie; Gorni, Ksenija; Govoni, Alessandra; Guglieri, Michela; Lochmuller, Hanns; et al. (2017). "Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: A randomised, double-blind, placebo-controlled phase 2 trial". The Lancet Neurology. 16 (7): 513. doi:10.1016/S1474-4422(17)30085-6. PMID 28460889.

ncbi.nlm.nih.gov

  • Martin LJ (August 2010). "Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis". IDrugs. 13 (8): 568–80. PMC 3058503. PMID 20721828.

trophos.com

ukmi.nhs.uk

web.archive.org